HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44
Molecules · 2023
DOI: 10.3390/molecules28227565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Bo Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Harbin University of Commerce, Harbin 150076, China. Hauptthemen laut MEDLINE: Nanoparticles, Colonic Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Harbin University of Commerce Youth Top Talent Program.
Abstract (Originalsprache)
Apigenin (API) possesses excellent antitumor properties but its limited water solubility and low bioavailability restrict its therapeutic impact. Thus, a suitable delivery system is needed to overcome these limitations and improve the therapeutic efficiency. Poly (lactic-co-glycolic acid) (PLGA) is a copolymer extensively utilized in drug delivery. Hyaluronic acid (HA) is a major extracellular matrix component and can specifically bind to CD44 on colon cancer cells. Herein, we aimed to prepare receptor-selective HA-coated PLGA nanoparticles (HA-PLGA-API-NPs) for colon cancers with high expression of CD44; chitosan (CS) was introduced into the system as an intermediate, simultaneously binding HA and PLGA through electrostatic interaction to facilitate a tighter connection between them. API was encapsulated in PLGA to obtain PLGA-API-NPs, which were then sequentially coated with CS and HA to form HA-PLGA-API-NPs. HA-PLGA-API-NPs had a stronger sustained-release capability. The cellular uptake of HA-PLGA-API-NPs was enhanced in HT-29 cells with high expression of CD44. In vivo, HA-PLGA-API-NPs showed enhanced targeting specificity towards the HT-29 ectopic tumor model in nude mice in comparison with PLGA-API-NPs. Overall, HA-PLGA-API-NPs were an effective drug delivery platform for API in the treatment of colon cancers with high expression of CD44.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Harbin University of Commerce, Harbin 150076, China.
- Department of Pharmacology, Medical College, University of Shaoxing, Shaoxing 312000, China.
- Heilongjiang Provincial Key Laboratory of Neurobiology, Department of Neurobiology, Harbin Medical University, Harbin 150086, China.
Förderung
- Harbin University of Commerce Youth Top Talent Program
Zitieren
APA
Yang, B., Mao, Y., Zhang, Y., Hao, Y., Guo, M., Li, B., & Peng, H. (2023). HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44. Molecules. https://doi.org/10.3390/molecules28227565
Vancouver
Yang B, Mao Y, Zhang Y, Hao Y, Guo M, Li B, et al. HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44. Molecules. 2023. doi:10.3390/molecules28227565
BibTeX
@article{Yang2023,
author = {Yang, Bo and Mao, Yongqing and Zhang, Yanjun and Hao, Yue and Guo, Meitong and Li, Bian and Peng, Haisheng},
title = {HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28227565}
}
EUVIMED